Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Debt (2020 - 2023)

Historic Total Debt for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $20.4 million.

  • Candel Therapeutics' Total Debt rose 157.54% to $20.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.4 million, marking a year-over-year increase of 157.54%. This contributed to the annual value of $20.2 million for FY2022, which is 350750.0% up from last year.
  • Per Candel Therapeutics' latest filing, its Total Debt stood at $20.4 million for Q3 2023, which was up 157.54% from $20.4 million recorded in Q2 2023.
  • Over the past 5 years, Candel Therapeutics' Total Debt peaked at $20.4 million during Q3 2023, and registered a low of $463000.0 during Q4 2020.
  • Moreover, its 4-year median value for Total Debt was $20.1 million (2022), whereas its average is $15.8 million.
  • Its Total Debt has fluctuated over the past 5 years, first surged by 350750.0% in 2022, then soared by 157.54% in 2023.
  • Candel Therapeutics' Total Debt (Quarter) stood at $463000.0 in 2020, then increased by 20.95% to $560000.0 in 2021, then soared by 3507.5% to $20.2 million in 2022, then increased by 1.17% to $20.4 million in 2023.
  • Its Total Debt was $20.4 million in Q3 2023, compared to $20.4 million in Q2 2023 and $20.3 million in Q1 2023.